A 10‐year review of surgical management of dermatofibrosarcoma protuberans
<p><strong>Background</strong></p> Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Standard treatment in the UK is either wide local excision (WLE) or Mohs micrographic surgery (MMS). It is unclear which approach has the lower recurrence rate. <p><stro...
| Main Authors: | , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2020
|
| _version_ | 1797109100092325888 |
|---|---|
| author | Durack, A Gran, S Gardiner, MD Jain, A Craythorne, E Proby, CM Marsden, J Harwood, CA Matin, RN |
| author2 | DFSP Collaborators |
| author_facet | DFSP Collaborators Durack, A Gran, S Gardiner, MD Jain, A Craythorne, E Proby, CM Marsden, J Harwood, CA Matin, RN |
| author_sort | Durack, A |
| collection | OXFORD |
| description | <p><strong>Background</strong></p>
Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Standard treatment in the UK is either wide local excision (WLE) or Mohs micrographic surgery (MMS). It is unclear which approach has the lower recurrence rate.
<p><strong>Objectives</strong></p>
We undertook a retrospective comparative review of surgical management of DFSP in the UK National Health Service in order to define (i) current surgical practice for primary and recurrent DFSP, (ii) local recurrence rates for primary DFSP and (iii) survival outcomes for DFSP.
<p><strong>Methods</strong></p>
A retrospective clinical case‐note review of patients with histologically confirmed DFSP (January 2004 to December 2013) who have undergone surgical treatment.
<p><strong>Results</strong></p>
The surgical management of 483 primary and 64 recurrent DFSP in 11 plastic surgery and 15 dermatology departments was analysed. Almost 75% of primary DFSP (n = 362) were treated with WLE and 20% (n = 97) with MMS. For recurrent DFSP, 69% (n = 44) and 23% (n = 15) of patients underwent WLE and MMS, respectively. Recurrent primary DFSP occurred in six patients after WLE and none after MMS. The median follow‐up time was 25·5 months (interquartile range 6·8–45·1) for new and 19·8 (IQR 4·5–44·5) for recurrent DFSP [Correction added on 1 Feb 2021, after first online publication: 4.8 years (interquartile range 3.5‐5.8) was incorrect], with eight reported deaths during the follow‐up analysis period (one confirmed to be DFSP related).
<p><strong>Conclusions</strong></p>
WLE was the most common surgical modality used to treat DFSP across the UK. The local recurrence rate was very low, occurring only after WLE. Although a prospective randomized controlled trial may provide more definitive outcomes, in the absence of a clearly superior surgical modality, treatment decisions should be based on patient preference, clinical expertise and cost. |
| first_indexed | 2024-03-07T07:37:14Z |
| format | Journal article |
| id | oxford-uuid:f5dbdcac-9768-4f07-a228-8211404df8e8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:37:14Z |
| publishDate | 2020 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:f5dbdcac-9768-4f07-a228-8211404df8e82023-03-14T11:19:17ZA 10‐year review of surgical management of dermatofibrosarcoma protuberansJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f5dbdcac-9768-4f07-a228-8211404df8e8EnglishSymplectic ElementsWiley2020Durack, AGran, SGardiner, MDJain, ACraythorne, EProby, CMMarsden, JHarwood, CAMatin, RNDFSP Collaborators<p><strong>Background</strong></p> Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Standard treatment in the UK is either wide local excision (WLE) or Mohs micrographic surgery (MMS). It is unclear which approach has the lower recurrence rate. <p><strong>Objectives</strong></p> We undertook a retrospective comparative review of surgical management of DFSP in the UK National Health Service in order to define (i) current surgical practice for primary and recurrent DFSP, (ii) local recurrence rates for primary DFSP and (iii) survival outcomes for DFSP. <p><strong>Methods</strong></p> A retrospective clinical case‐note review of patients with histologically confirmed DFSP (January 2004 to December 2013) who have undergone surgical treatment. <p><strong>Results</strong></p> The surgical management of 483 primary and 64 recurrent DFSP in 11 plastic surgery and 15 dermatology departments was analysed. Almost 75% of primary DFSP (n = 362) were treated with WLE and 20% (n = 97) with MMS. For recurrent DFSP, 69% (n = 44) and 23% (n = 15) of patients underwent WLE and MMS, respectively. Recurrent primary DFSP occurred in six patients after WLE and none after MMS. The median follow‐up time was 25·5 months (interquartile range 6·8–45·1) for new and 19·8 (IQR 4·5–44·5) for recurrent DFSP [Correction added on 1 Feb 2021, after first online publication: 4.8 years (interquartile range 3.5‐5.8) was incorrect], with eight reported deaths during the follow‐up analysis period (one confirmed to be DFSP related). <p><strong>Conclusions</strong></p> WLE was the most common surgical modality used to treat DFSP across the UK. The local recurrence rate was very low, occurring only after WLE. Although a prospective randomized controlled trial may provide more definitive outcomes, in the absence of a clearly superior surgical modality, treatment decisions should be based on patient preference, clinical expertise and cost. |
| spellingShingle | Durack, A Gran, S Gardiner, MD Jain, A Craythorne, E Proby, CM Marsden, J Harwood, CA Matin, RN A 10‐year review of surgical management of dermatofibrosarcoma protuberans |
| title | A 10‐year review of surgical management of dermatofibrosarcoma protuberans |
| title_full | A 10‐year review of surgical management of dermatofibrosarcoma protuberans |
| title_fullStr | A 10‐year review of surgical management of dermatofibrosarcoma protuberans |
| title_full_unstemmed | A 10‐year review of surgical management of dermatofibrosarcoma protuberans |
| title_short | A 10‐year review of surgical management of dermatofibrosarcoma protuberans |
| title_sort | 10 year review of surgical management of dermatofibrosarcoma protuberans |
| work_keys_str_mv | AT duracka a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT grans a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT gardinermd a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT jaina a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT craythornee a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT probycm a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT marsdenj a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT harwoodca a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT matinrn a10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT duracka 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT grans 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT gardinermd 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT jaina 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT craythornee 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT probycm 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT marsdenj 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT harwoodca 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans AT matinrn 10yearreviewofsurgicalmanagementofdermatofibrosarcomaprotuberans |